GlassScriptPhysician profile
Jondavid Pollock
NPI 1831167048
$1,118.17
in general payments reported to CMS, 2019-2025
13 companies · $45.69 in 2025
The $45.69 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $853 · 2020: $191 · 2023: $28.57 · 2025: $45.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $74.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $74.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $189.43 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $179.37 | 2019-2020 | |
| Astellas Pharma US INC | $163.96 | 2019-2020 | |
| Pfizer INC. | $130.72 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.96 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $119.34 | 2019-2025 | Keytruda |
| Boston Scientific Corporation | $67.72 | 2019-2025 | Spaceoar System |
| Dendreon Pharmaceuticals LLC | $38.00 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $34.59 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $28.57 | 2023 | Orgovyx |
| Sun Pharmaceutical Industries INC. | $15.51 | 2019 | |
| Janssen Biotech, INC. | $12.54 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jondavid Pollock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.